Chetan Shenoy
banner
cshenoy.bsky.social
Chetan Shenoy
@cshenoy.bsky.social
Cardiologist and researcher, in cardiovascular magnetic resonance imaging, at the University of Minnesota
October 6, 2025 at 2:17 PM
Interesting. The ECV increased 1.1% (25 min) to 2.2% (5 min), which is difficult to explain. But it explains why LGE was less; it was quantified as the amount of myocardium 6SD brighter than "remote". LGE amount will be less if the remote myocardium is brighter after mavacamten than at baseline.
July 13, 2025 at 3:40 PM
Prediction of ventricular arrhythmic outcomes in suspected cardiac sarcoidosis: a comparison of cardiovascular magnetic resonance phenotyping vs. societal recommendations for implantable cardioverter-defibrillator placement

academic.oup.com/eurheartj/ad...

#Cardiosky #WhyCMR #Epeeps #Medsky
May 27, 2025 at 1:32 PM
academic.oup.com/eurheartj/ad...

@escardio.bsky.social
#Cardiosky #WhyCMR #Epeeps #Medsky

Please DM me if you would like a full-text PDF of the paper!
May 24, 2025 at 2:39 PM
We discuss this in our editorial:
academic.oup.com/ehjcimaging/...
March 23, 2025 at 2:29 AM
A new study in EHJ - Cardiovascular Imaging describes 324 patients with normal CMR and no high-risk features who all also had FDG-PET.

21.3% had FDG uptake.

Their annualized event rate was <1%, indicating that FDG-PET has little diagnostic or prognostic utility.
March 21, 2025 at 11:39 PM
In patients with suspected cardiac sarcoidosis, cardiac FDG-PET is recommended after a normal CMR if there is a high clinical suspicion. What are the data supporting this recommendation? #CardioSky #MedSky #Sarcoidosis
March 21, 2025 at 11:39 PM
January 5, 2025 at 6:22 PM
January 5, 2025 at 6:15 PM
Amazing achievement by rising star and post-doc in my lab @paragbawaskar.bsky.social, winner of the prestigious 2024 Melvin Judkins Early Career Investigator Award at #AHA24!! Congratulations!!!
@ahascience.bsky.social
November 17, 2024 at 3:46 PM
Our study is 1 of 5 studies featured on the latest episode of ESC TV Today (from 6 min 35s to 8 min 18 s):

esc365.escardio.org/event/1794
November 12, 2024 at 7:34 PM
In a longitudinal study of 107 LV thrombus patients with >1 serial CMR (213 total CMRs), we found that resolution rates were only 25% at 3 months, 47% at 6 months, and 63% at 12 months!

We recently published this paper led by the talented @paragbawaskar.bsky.social

academic.oup.com/ehjcimaging/...
November 12, 2024 at 7:34 PM
In 2019, we wrote a paper showing that patients with left ventricular thrombus have a long-term risk of embolism, extending to at least 8 years.

We were puzzled by the finding…

#CardioSky

www.ahajournals.org/doi/10.1161/...
November 12, 2024 at 7:34 PM
Read our editorial on avoiding errors when diagnosing myocarditis using CMR:

www.sciencedirect.com/science/arti...

@paragbawaskar.bsky.social

#CardioSky
October 19, 2024 at 4:00 PM